Literature DB >> 21160046

Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis.

Eva Pastille1, Sonja Didovic, Daniela Brauckmann, Meenakshi Rani, Hemant Agrawal, F Ulrich Schade, Yang Zhang, Stefanie B Flohé.   

Abstract

Murine polymicrobial sepsis is associated with a sustained reduction of dendritic cell (DC) numbers in lymphoid organs and with a dysfunction of DC that is considered to mediate the chronic susceptibility of post-septic mice to secondary infections. We investigated whether polymicrobial sepsis triggered an altered de novo formation and/or differentiation of DC in the bone marrow. BrdU labeling experiments indicated that polymicrobial sepsis did not affect the formation of splenic DC. DC that differentiated from bone marrow (bone marrow-derived DC [BMDC]) of post-septic mice released enhanced levels of IL-10 but did not show an altered phenotype in comparison with BMDC from sham mice. Adoptive transfer experiments of BMDC into naive mice revealed that BMDC from post-septic mice impaired Th1 priming but not Th cell expansion and suppressed the innate immune defense mechanisms against Pseudomonas bacteria in the lung. Accordingly, BMDC from post-septic mice inhibited the release of IFN-γ from NK cells that are critical for the protection against Pseudomonas. Additionally, sepsis was associated with a loss of resident DC in the bone marrow. Depletion of resident DC from bone marrow of sham mice led to the differentiation of BMDC that were impaired in Th1 priming similar to BMDC from post-septic mice. Thus, in response to polymicrobial sepsis, DC precursor cells in the bone marrow developed into regulatory DC that impaired Th1 priming and NK cell activity and mediated immunosuppression. The absence of resident DC in the bone marrow after sepsis might have contributed to the modulation of DC differentiation.

Entities:  

Mesh:

Year:  2010        PMID: 21160046     DOI: 10.4049/jimmunol.1001147

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.

Authors:  Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 2.  Immunopathogenesis of abdominal sepsis.

Authors:  Georg F Weber; Filip K Swirski
Journal:  Langenbecks Arch Surg       Date:  2014-01       Impact factor: 3.445

3.  Lipopeptides rather than lipopolysaccharide favor the development of dendritic cell dysfunction similar to polymicrobial sepsis in mice.

Authors:  Stephanie Bruns; Eva Pastille; Florian Wirsdörfer; Marion Frisch; Stefanie B Flohé
Journal:  Inflamm Res       Date:  2013-04-03       Impact factor: 4.575

Review 4.  Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity.

Authors:  Derek B Danahy; Robert K Strother; Vladimir P Badovinac; Thomas S Griffith
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

5.  When host defense goes awry: Modeling sepsis-induced immunosuppression.

Authors:  Scott B Hu; Alexander Zider; Jane C Deng
Journal:  Drug Discov Today Dis Models       Date:  2012

6.  Polymicrobial Sepsis Diminishes Dendritic Cell Numbers and Function Directly Contributing to Impaired Primary CD8 T Cell Responses In Vivo.

Authors:  Robert K Strother; Derek B Danahy; Dmitri I Kotov; Tamara A Kucaba; Zeb R Zacharias; Thomas S Griffith; Kevin L Legge; Vladimir P Badovinac
Journal:  J Immunol       Date:  2016-10-26       Impact factor: 5.422

Review 7.  Sepsis-induced immune dysfunction: can immune therapies reduce mortality?

Authors:  Matthew J Delano; Peter A Ward
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

Review 8.  The significance and regulatory mechanisms of innate immune cells in the development of sepsis.

Authors:  Ying-Yi Luan; Ning Dong; Meng Xie; Xian-Zhong Xiao; Yong-Ming Yao
Journal:  J Interferon Cytokine Res       Date:  2013-09-05       Impact factor: 2.607

Review 9.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

Review 10.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.